Xu Song
Papers
1
Total Citations
31
H-Index
1
About
Xu Song is a prominent researcher specializing in medical device regulation, healthcare innovation, and translational medicine within the Chinese biomedical landscape. His work sits at the critical intersection of regulatory science, industry development, and technological advancement, making him a vital voice in shaping how medical devices are evaluated, approved, and brought to market in China. His most notable contribution, "Advancing Medical Device Regulatory Reforms for Innovation, Translation and Industry Development in China" (2022), has garnered 31 citations and stands as a key reference for policymakers, industry stakeholders, and researchers navigating China's rapidly evolving regulatory environment. In this influential work, Xu Song examines the growing Chinese medical device market and advocates for a rigorous, science-based regulatory framework capable of supporting both domestic innovation and international competitiveness. By documenting the latest regulatory requirements and reform initiatives, his research provides actionable guidance for bridging the gap between laboratory discovery and clinical application. Xu Song's scholarship is particularly valuable for students and researchers seeking to understand how regulatory infrastructure influences the pace and direction of medical technology development, offering critical insights into one of the world's most dynamic and consequential healthcare markets.
Research Focus
Key Achievements
Top Papers
- 1